FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion
- 8 November 1999
- journal article
- Published by Wiley in FEBS Letters
- Vol. 461 (1-2), 91-95
- https://doi.org/10.1016/s0014-5793(99)01427-1
Abstract
Frontal temporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) is caused by splice site and missense mutations in the tau gene, and characterized by the accumulation of filamentous tau in cerebral neurons and glia. The missense mutations reduce the ability of tau to promote microtubule assembly and increase the ability of tau to form filaments. In this report we demonstrate that mutants V337M and R406W are less susceptible than mutant P301L or corresponding wild type tau to degradation by calpain I. The differences were at least in part due to changes in accessibility of a cleavage site located about 100 amino acids off the carboxy-terminus. The results suggest that the pathogenesis of some forms of FTDP-17 may involve tau accumulation due to decreased proteolytic degradation.Keywords
This publication has 26 references indexed in Scilit:
- Stable Expression in Chinese Hamster Ovary Cells of Mutated Tau Genes Causing Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17)The American Journal of Pathology, 1999
- Accelerated filament formation from tau protein with specific FTDP‐17 missense mutationsFEBS Letters, 1999
- Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutationsFEBS Letters, 1999
- Tau Pathology in Two Dutch Families with Mutations in the Microtubule-Binding Region of TauThe American Journal of Pathology, 1998
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Degradation of Tau by Lysosomal Enzyme Cathepsin D: Implication for Alzheimer Neurofibrillary DegenerationJournal of Neurochemistry, 1997
- Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conferenceAnnals of Neurology, 1997
- The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease PathologyJournal of Biological Chemistry, 1996
- Application of synthetic phospho‐ and unphospho‐ peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's diseaseJournal of Neuroscience Research, 1993
- The distribution of tau in the mammalian central nervous system.The Journal of cell biology, 1985